Genetically Defined Strains in Drug Development and Toxicity Testing.

Abstract excerpt

There is growing concern about the poor quality and lack of repeatability of many pre-clinical experiments involving laboratory animals. According to one estimate as much as $28 billion is wasted annually in the USA alone in such studies. A decade ago the FDA's "Critical path" white paper noted that "The traditional tools used to assess product safety-animal toxicology and outcomes from human studies-have changed...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Animals, Laboratory
• Share to Drug Evaluation, Preclinical
• Share to Guidelines as Topic